Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

At our Pancreatic Cancer Center, we create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies.

Clinical Trials and Research Studies

Phase 2

A Randomized Phase 2 Study of Losartan and Nivolumab in Combination with FOLFIRINOX and SBRT in Localized Pancreatic Cancer (Stand up to Cancer)

Learn More

Phase 1/2

A Phase l/ll Open-Label Study to Investigate the Safety Clinical Activity Pharmacokinetics and Pharmacodynamics of GSK3145095 Administered Alone and in Combination with Anticancer Agents Including Pembrolizumab in Adult Participants with Selected Advanced Solid Tumors

Learn More

Phase 2

A phase II study of nivolumab cabiralizumab and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer

Learn More

Phase 2

A Phase 2 Study of Cabiralizumab (BMS-986227 FPA008) Administered in Combination with Nivolumab (BMS-936558) with and without Chemotherapy in Patients with Advanced Pancreatic Cancer relating to BMS Compounds: BMS-986227 FPA008

Learn More